Men's cancer: Help fund new ways to diagnose and treat these diseases
Last updated: 10/08/2012
Why this research is needed
Almost 40,000 men are diagnosed with prostate, testicular, or penile cancer in the UK every year.
The majority are diagnosed with prostate cancer, which accounts for around 37,000 cases. Around 2,000 men are diagnosed with testicular cancer and around 490 men are diagnosed with penile cancer.
The impact of our work
In the 1970s, our researchers played a key role in the development of cisplatin – a drug that has transformed the treatment of advanced testicular cancer and is also used in the treatment of advanced penile cancer.
Our scientists were also involved in the discovery and development of abiraterone, which last year showed great promise in a large clinical trial by providing men with advanced prostate cancer with valuable extra months of life.
Please support our scientists as they work to find new ways to prevent, diagnose and treat "men only" cancers.
Let your friends and family know about this project to get them involvedShare this project
Our work into men’s cancers
We're conducting a wide range of research to find new ways to prevent, diagnose and treat men’s cancers. Here are some examples of our work:
Different approaches to treating prostate cancer
Professor David Neal is a surgeon and a leading expert on prostate cancer. He and his colleagues in Cambridge are tackling a number of different approaches to help beat this disease.
The team is looking for better ways to tell an aggressive prostate cancer from a non-aggressive cancer so that men can be given the right treatment.
Professor Neal is also investigating the genes behind prostate cancer which could help discover why the disease develops and reveal new ways to treat it.
Minimising the side effects of cancer treatment
Professor Richard Ross at the University of Sheffield is working to find out if testosterone can help minimise some of the long term side effects of treatment for young men who beat cancer, including testicular cancer. These side effects can vary, but can include being more likely to put on weight, which could have other health effects in later life. This study could help improve the long-term quality of life for young men who have suffered from cancer.
Chemotherapy for penile cancer
Dr Emma Hall at the Institute of Cancer Research has finished recruiting people to take part in her clinical trial to find out the best chemotherapy regime for people with advanced penile cancer. Dr Hall and her team will now assess if this new combination of drugs helps men with the disease.
The difference you can make
It is vital that we continue this range of research to beat men’s cancers and improve the outlook for men affected by them. We receive no Government funding for our research so we rely on the support of the public to continue our groundbreaking work.
The cost of running a project like Professor Ross’s is around £70,000 a year. By supporting our work, you could help us beat men's cancers by discovering new ways to prevent, diagnose and treat them.
Donate now and you can help support: Men's cancer: Help fund new ways to diagnose and treat these diseases